MENS
Jyong Biotech Ltd. Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$192.35M
P/E Ratio
—
EPS
$-0.04
Beta
—
52W High
$67.00
52W Low
$1.43
50-Day MA
$2.14
200-Day MA
$23.94
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. (ticker: MENS) is an innovative biotechnology company specializing in the development of cutting-edge therapeutic solutions for cancer and autoimmune disorders. Leveraging advanced genomics and molecular biology research, the firm boasts a promising pipeline of therapies supported by a strong intellectual property portfolio. Strategic partnerships within the biopharmaceutical sector further enhance its market position, enabling Jyong Biotech to capitalize on emerging opportunities while maintaining a steadfast commitment to scientific excellence and patient-centric care, ensuring a substantial impact on healthcare advancements.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-1.80M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -5.44% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.31 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $74.23M |
| Float | $27.63M |
| % Insiders | 62.20% |
| % Institutions | 1.03% |
Data last updated: 4/8/2026